Skip to Content


Susan Ott, M.D.

Metabolism, Endocrinology and Nutrition

Professor of Medicine


Clinical and bone histomorphometric studies of bone metabolism. Effects of contraception and lifestyle on bone density in adolescents; mineralization density of bone; bone histomorphometry of women with breast cancer; renal osteodystrophy.


Ott SM, Chesnut CH: Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 110:267-274, 1989.

Ott SM, Lipkin EW, Newell-Morris L:  Bone physiology during pregnancy and lactation in young macaques.  J Bone Mineral Res 14:1779-1788, 1999.

Ott SM, Oleksik A, Lu Y, Harper K, Lips P:  Bone histomorphometric and biochemical marker results of a two-year placebo controlled trial of Raloxifene in postmenopausal women.  J Bone Mineral Res 17:341-348, 2002.

Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM:  Injectable hormone contraception and bone density:  Results from a prospective study.  Epidemiology 13:581-587, 2002.

Ott SM:  Long-term safety of bisphosphonates.  J Clin Endocrinol Metab 90:1897-1899, 2005.

Ott SM:  Sclerostin and Wnt signaling–the pathway to bone strength.  J Clin Endocrinol Metab 90:6741-6743, 2005.

Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G, Kidney Disease: Improving Global Outcomes (KDIGO):  Definition, evaluation, and classification of renal osteodystrophy:  a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).  Kidney Int 69:1945-1953, 2006.

Other Website

Visit Dr. Ott’s osteoporosis web site at